Bliss GVS Pharma Ltd Quarterly Results

Gross Sales

207.47

197.99

210.42

217.68

183.64

Excise Duty

0

0

0

0

0

Net Sales

207.47

197.99

210.42

217.68

183.64

Other Operating Income

0

0

0

0

0

Other Income

35.45

12.07

15.27

5.04

4.12

Total Income

242.92

210.05

225.68

222.72

187.77

Total Expenditure

166.14

176.9

180.63

176.2

149.31

PBIDT

76.78

33.15

45.05

46.51

38.45

Interest

5.47

1.68

1.08

3.83

1.53

PBDT

71.31

31.48

43.97

42.69

36.92

Depreciation

8.2

8.04

7.55

6.98

6.85

Minority Interest Before NP

0

0

0

0

0

Tax

20.49

5.9

13.76

11.09

8.63

Deferred Tax

-1.75

0.89

-3.14

-1.08

-0.67

Reported Profit After Tax

44.36

16.65

25.8

25.69

22.11

Minority Interest After NP

1.32

1.11

2

1.43

1.41

Net Profit after Minority Interest

43.04

15.54

23.8

24.26

20.7

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

43.04

15.54

23.8

24.26

20.7

EPS (Unit Curr.)

4.08

1.47

2.27

2.31

1.97

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

10.55

10.54

10.54

10.51

10.49

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

37

16.74

21.4

21.36

20.93

PBDTM(%)

34.37

15.89

20.89

19.61

20.1

PATM(%)

21.38

8.4

12.26

11.8

12.03